Lenacapavir, the revolutionary HIV drug, still hasn’t reached Latin America

Lenacapavir, the revolutionary HIV drug, still hasn’t reached Latin America

Two injections a year. That’s all it takes to protect against HIV with lenacapavir, a revolutionary drug hailed as potentially the beginning of the end of the epidemic, but its rollout has been slow. It has efficacy close to 100% and is already being distributed in small quantities in nine priority African countries. In middle-income countries such as those in Latin America it has not yet arrived, despite the fact that their residents took part …